The Technical Analyst
SPDR S&P Pharmaceuticals [XPH]
Exchange: NYSE
SPDR S&P Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.52% $40.93
America/New_York / 8 mai 2024 @ 15:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 225.13 mill |
| EPS: | 2.78 |
| P/E: | 14.73 |
| Earnings Date: | N/A |
| SharesOutstanding: | 5.50 mill |
| Avg Daily Volume: | 0.0361 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.62x |
| Company: PE 14.73 | sector: PE 23.85 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.09x |
| Company: PE 14.73 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 40.31 - 41.55 ( +/- 1.52%) |
| ATR Model: 14 days |
Forecast:
16:00 - $40.93
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $40.93
Forecast 2: 16:00 - $40.93
Forecast 3: 16:00 - $40.93
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $40.93 (0.52% ) |
| Volume | 0.0199 mill |
| Avg. Vol. | 0.0361 mill |
| % of Avg. Vol | 55.13 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For XPH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
XPH
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Latest News
2024-05-07 12:31:03 - Zacks Investment Research
A Look at Pharma ETFs Post Q1 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
2024-02-15 07:21:04 - Zacks Investment Research
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
2024-02-14 07:21:22 - Zacks Investment Research
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
2024-02-12 14:01:05 - Zacks Investment Research
A Look at Pharma ETFs After Q4 Earnings
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
2023-12-15 07:31:16 - Zacks Investment Research
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
2023-12-14 07:31:08 - Zacks Investment Research
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
2023-11-08 12:46:40 - Zacks Investment Research
Pharma ETFs in Focus Post Q3 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
2023-09-18 07:32:09 - Zacks Investment Research
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Care ETFs category of the market.
2023-08-21 07:31:22 - Zacks Investment Research
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
2023-08-11 13:47:31 - Zacks Investment Research
Pharma ETFs in Focus Post Q2 Earnings
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.